Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06075524
What this trial is testing

Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Lung Carcinoma+7 more
Mayo Clinic 500
Early research (Phase 1)Study completedNCT00085462
What this trial is testing

Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Institutes of Health Clinical Center (CC) 61
Early research (Phase 1)Study completedNCT01765569
What this trial is testing

A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma, Neoplasms
Hoffmann-La Roche 29
Testing effectiveness (Phase 2)Study completedNCT01189383
What this trial is testing

IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Baylor Research Institute 20
Early research (Phase 1)Study completedNCT02437227
What this trial is testing

Dose Escalation Study With Expansion to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of CCT3833

Who this might be right for
MelanomaCancer
Royal Marsden NHS Foundation Trust 31
Early research (Phase 1)WithdrawnNCT02068079
What this trial is testing

A Pilot Study of Trientine With Vemurafenib for the Treatment BRAF Mutated Metastatic Melanoma

Who this might be right for
Melanoma
Duke University
Early research (Phase 1)Study completedNCT01052142
What this trial is testing

Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma

Who this might be right for
Melanoma
Lipotek Pty Ltd 12
Testing effectiveness (Phase 2)Ended earlyNCT00612222
What this trial is testing

Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 4
Testing effectiveness (Phase 2)Study completedNCT02678741
What this trial is testing

Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.

Who this might be right for
Metastatic Melanoma
Elios Therapeutics, LLC 26
Not applicableEnded earlyNCT05848219
What this trial is testing

Healthcare Resource Utilization and Costs in Metastatic Melanoma Patients Initiated Dabrafenib + Trametinib and Encorafenib + Binimetinib

Who this might be right for
Metastatic Melanoma
Novartis Pharmaceuticals 543
Not applicableStudy completedNCT01960634
What this trial is testing

Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma

Who this might be right for
Stage IV Skin Melanoma
Grupo Español Multidisciplinar de Melanoma 58
Testing effectiveness (Phase 2)Study completedNCT00026221
What this trial is testing

Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 57
Not applicableStudy completedNCT03493230
What this trial is testing

Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients With Metastatic Malignant Melanoma Treated With Targeted Therapies or Immunotherapy ( MALT )

Who this might be right for
Malignant Melanoma Stage IVMalignant Melanoma Stage III
Centre Hospitalier Universitaire de Nice 35
Testing effectiveness (Phase 2)Study completedNCT00019669
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT02303951
What this trial is testing

Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VC

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 47
Early research (Phase 1)Temporarily pausedNCT05629546
What this trial is testing

Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

Who this might be right for
Advanced MelanomaMetastatic Melanoma
Washington University School of Medicine 33
Testing effectiveness (Phase 2)Study completedNCT00014625
What this trial is testing

E7070 in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 28
Not applicableWithdrawnNCT01312506
What this trial is testing

Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls

Who this might be right for
Metastatic MelanomaCNS Metastases
University of Pittsburgh
Not applicableLooking for participantsNCT06784778
What this trial is testing

Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy.

Who this might be right for
Melanoma MetastaticMelanoma, SkinMelanoma Stage III or IV+1 more
Pamgene International B.V. 196
Testing effectiveness (Phase 2)Ended earlyNCT06984328
What this trial is testing

Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)

Who this might be right for
Cutaneous MelanomaRelapsed/Refractory, Locally Advanced Unresectable Melanoma (Stage IIIB, IIIC, or IIID)Metastatic Cutaneous Melanoma (Stage IV)
Genmab 1
Next Page